Literature DB >> 19642876

The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.

Marie-Luise Berres1, Christian Trautwein, Mirko Moreno Zaldivar, Petra Schmitz, Katrin Pauels, Sergio A Lira, Frank Tacke, Hermann E Wasmuth.   

Abstract

The chemokine decoy receptor D6 is a promiscuous chemokine receptor lacking classical signaling functions. It negatively regulates inflammation by targeting CC chemokines to cellular internalization and degradation. Here we analyze the function of D6 in acute CCl(4)-induced liver damage in constitutive D6(-/-) and wild-type mice. The degree of liver injury was assessed by liver histology, serum transaminases, IL-6, and TNFalpha mRNA expression. Protein levels of D6 ligands (CCL2, CCL3, CCL5) and the non-D6-ligand CXCL9 within the livers were determined by ELISAs. The intrahepatic infiltration of immune cells was characterized by FACS. Genetic deletion of D6 led to prolonged liver damage after acute CCl(4) administration. The augmented liver damage in D6(-/-) mice was associated with increased protein levels of intrahepatic inflammatory chemokines CCL2, CCL3, and CCL5 after 48 h, whereas CXCL9 was not different between knockout and wild-type mice. Functionally, increased intra-hepatic CC chemokine concentrations led to increased infiltration of CD45(+) leukocytes, which were mainly identified as T and NK cells. In conclusion, the chemokine scavenger receptor D6 has a non-redundant role in acute toxic liver injury in vivo. These results support the importance of post-translational chemokine regulation and describe a new mechanism of immune modulation within the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19642876     DOI: 10.1515/BC.2009.119

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 2.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 3.  DARC and D6: silent partners in chemokine regulation?

Authors:  Chris A H Hansell; Catherine E Hurson; Robert J B Nibbs
Journal:  Immunol Cell Biol       Date:  2010-12-14       Impact factor: 5.126

Review 4.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

Review 5.  Atypical chemokine receptors.

Authors:  Maria Helena Ulvmar; Elin Hub; Antal Rot
Journal:  Exp Cell Res       Date:  2011-01-25       Impact factor: 3.905

6.  Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course.

Authors:  Chuanshan Zhang; Junhua Wang; Guodong Lü; Jing Li; Xiaomei Lu; Georges Mantion; Dominique A Vuitton; Hao Wen; Renyong Lin
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

7.  The role of chemokines in acute liver injury.

Authors:  Yedidya Saiman; Scott L Friedman
Journal:  Front Physiol       Date:  2012-06-20       Impact factor: 4.566

8.  The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.

Authors:  Chris A H Hansell; Lindsay M MacLellan; Rachel S Oldham; James Doonan; Katie J Chapple; Elinor J R Anderson; Christopher Linington; Iain B McInnes; Robert J B Nibbs; Carl S Goodyear
Journal:  Immunol Cell Biol       Date:  2014-10-28       Impact factor: 5.126

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

Review 10.  The role of chemokines in hepatitis C virus-mediated liver disease.

Authors:  Anette Brass; Erwin Daniel Brenndörfer
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.